At Nephron Research, our mission is to be essential to our clients’ investment process.
As the market’s leading independent healthcare equity research provider, we strive to separate market noise from the insights that are essential to the investment process.
Nephron’s primary differentiators lie in our research teams and their approach to equity research. The deep experience and insight of our analysts as well as an intense drive to serve a discerning client base sets us apart. With the sole focus of creating value for clients, Nephron can provide a depth of coverage, breadth of access, and consultative services that traditional models lack.
Delivered via an independent and unbiased subscription-only model, Nephron is directly aligned with our client’s interests and investment processes
Meet The Team
At Nephron Research, our experience and connectivity drive deep research products which is supplemented by hyper-relevant corporate access
Process Drives We tackle the most important debates, react quickly, and provide leading perspective
2021 MA Notice Takes a Step Back From a Very Positive Starting Point
Download
Nephron January Price Auditor: Brand Steady at +4.3%; Generic Deflation Declines to -2.5%
Download
A Closer Look: Cigna/ESI Makes Waves with Ascent Contracting & Econdisc Sourcing GPOs
DownloadNephron Research Curates Dozens of Events Each Year Designed for Maximum Impact to Client Investment Process
Timely tour of companies that are impacting the healthcare services landscape. Some are large and disruptive like Kaiser, and others are smaller and potentially new to our audience.
Our most heavily attended symposium of the year, the Pharmacy Benefit Management Innovation symposium remains relevant for both biopharma and healthcare services investors.
Gorman is THE go-to expert on all things Medicare Advantage. Gorman founded and grew Gorman Health Group into an industry leading consultancy after spending time at CMS (when it was HCFA). Gorman recently left GHG to create Nightingale Partners.
Our independent model and deep healthcare and investment expertise allows us to deliver a full suite of bespoke
and consultative services to investment firms and market participants.
